(2)
NEW YORK, NY / ACCESSWIRE / January 19, 2021 / Focus Financial Partners Inc. (NASDAQ:FOCS) ( Focus ), a leading partnership of independent, fiduciary wealth management firms, announced today that it is launching a transaction to increase the size of its First Lien Term Loan ( Term Loan ) by $375 million. Focus expects to close this transaction in January 2021 and use the proceeds to repay outstanding borrowings under its $650 million First Lien Revolver ( Revolver ). There will be no change to the existing terms of the Revolver as a result of this reduction in borrowings. As of December 31, 2020, the balances outstanding under Focus Term Loan and Revolver were approximately $1.13 billion and $380 million, respectively.
Hill Investment Group to Join Focus as a Partner Firm, Further Strengthening Focus Presence in the Midwest tennesseedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tennesseedaily.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, NY / ACCESSWIRE / January 15, 2021 / Focus Financial Partners Inc. (NASDAQ:FOCS) ("Focus"), a leading partnership of independent, fiduciary wealth management firms, announced today that Hill
Idorsia Pharmaceuticals Ltd
Idorsia to debut at the 39th J.P. Morgan Healthcare Conference – Major catalysts expected in the near-term – Daridorexant NDA submitted to the US FDA
Idorsia to debut at the 39th J.P. Morgan Healthcare Conference – Major catalysts expected in the near-term – Daridorexant NDA submitted to the US FDA
• Daridorexant new drug application (NDA) submitted to the US Food & Drug Administration (FDA) on January 8, 2021
Allschwil, Switzerland – January 11, 2021
Idorsia Ltd (SIX: IDIA) today announced that Jean-Paul Clozel, Chief Executive Officer of Idorsia, will present at the 39
th J. P. Morgan Healthcare Conference on January 12, 2021 at 09:10 Eastern Time / 15:10 Central European Time. The conference will take place fully virtual.